Atlas Trials

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Clinical trial NCT06183736 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06183736
Sponsor
Convalife (Shanghai) Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2023-12-20
Primary completion
2025-06-30
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.